Literature DB >> 30991908

Outcomes of Psychoeducation and a Text Messaging Adherence Intervention Among Individuals With Hypertension and Bipolar Disorder.

Jennifer B Levin1, Martha Sajatovic1, Mahboob Rahman1, Michelle E Aebi1, Curt Tatsuoka1, Colin Depp1, Clint Cushman1, Elaine Johnston1, Kristin A Cassidy1, Carol Blixen1, Logan Eskew1, Peter J Klein1, Edna Fuentes-Casiano1, David J Moore1.   

Abstract

OBJECTIVE: This study evaluated the feasibility, acceptability, and preliminary efficacy of psychoeducation plus an automated text messaging intervention (Individualized Texting for Adherence Building-Cardiovascular [iTAB-CV]) to improve adherence to antihypertensives and bipolar disorder medication.
METHODS: After a psychoeducation program, iTAB-CV was administered for 2 months. In month 1, participants received one educational-motivational and one mood rating text daily. In month 2, medication reminders were added.
RESULTS: The sample (N=38) was 74% African American and 53% women, with a mean±SD age of 51.53±9.06. Antihypertensive nonadherence decreased from a mean of 43%±23% to 21%±18% at 12 weeks (χ2=34.6, df=3, p<0.001). Systolic blood pressure decreased from a mean of 144.8±15.5 mmHg to 136.0±17.8 mmHg (χ2=17.6, df=3, p<.001). Retention was 100%.
CONCLUSIONS: In this uncontrolled trial, participants were highly engaged and medication adherence and reduced systolic blood pressure were sustained after psychoeducation plus iTAB-CV. Because iTAB-CV is automated and delivered remotely, it has the potential to reach a large and challenging population.

Entities:  

Keywords:  bipolar disorder; hypertension; m-Health; medication adherence; text messaging

Mesh:

Year:  2019        PMID: 30991908      PMCID: PMC6602799          DOI: 10.1176/appi.ps.201800482

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  12 in total

1.  Nonadherence with mood stabilizers: prevalence and predictors.

Authors:  Jan Scott; Marie Pope
Journal:  J Clin Psychiatry       Date:  2002-05       Impact factor: 4.384

Review 2.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

5.  Meta-analysis of the brief psychiatric rating scale factor structure.

Authors:  Alan Shafer
Journal:  Psychol Assess       Date:  2005-09

6.  Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder.

Authors:  David J Moore; Amelia Poquette; Kaitlin B Casaletto; Ben Gouaux; Jessica L Montoya; Carolina Posada; Alexandra S Rooney; Jayraan Badiee; Reena Deutsch; Scott L Letendre; Colin A Depp; Igor Grant; J Hampton Atkinson
Journal:  AIDS Behav       Date:  2015-03

Review 7.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

Review 9.  Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis.

Authors:  Jay Thakkar; Rahul Kurup; Tracey-Lea Laba; Karla Santo; Aravinda Thiagalingam; Anthony Rodgers; Mark Woodward; Julie Redfern; Clara K Chow
Journal:  JAMA Intern Med       Date:  2016-03       Impact factor: 21.873

10.  Racial/Ethnic disparities in the awareness, treatment, and control of hypertension - United States, 2003-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-05-10       Impact factor: 17.586

View more
  4 in total

1.  Differential Medication Attitudes to Antihypertensive and Mood Stabilizing Agents in response to an Automated Text-Messaging Adherence Enhancement Intervention.

Authors:  Peter Klein; Michelle E Aebi; Martha Sajatovic; Colin Depp; David Moore; Carol Blixen; Jennifer B Levin
Journal:  J Behav Cogn Ther       Date:  2020-07-17

2.  A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.

Authors:  Jennifer B Levin; Farren Briggs; Carol Blixen; Mark Bauer; Douglas Einstadter; Jeffrey M Albert; Celeste Weise; Nicole Woods; Edna Fuentes-Casiano; Kristin A Cassidy; Julie Rentsch; Kaylee Sarna; Martha Sajatovic
Journal:  Trials       Date:  2022-08-04       Impact factor: 2.728

Review 3.  Mobile health strategies for blood pressure self-management in urban populations with digital barriers: systematic review and meta-analyses.

Authors:  Elaine C Khoong; Kristan Olazo; Natalie A Rivadeneira; Sneha Thatipelli; Jill Barr-Walker; Valy Fontil; Courtney R Lyles; Urmimala Sarkar
Journal:  NPJ Digit Med       Date:  2021-07-22

Review 4.  Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review.

Authors:  Michael J Doane; Kristine Ogden; Leona Bessonova; Amy K O'Sullivan; Mauricio Tohen
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-16       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.